First Week of ADAP April 17th Options Trading Tuesday, March 10, 12:05 PM ET, by Market News Video Staff Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the ...
ADAP Crosses Above Average Analyst Target Wednesday, June 17, 7:33 AM ET, by Market News Video Staff In recent trading, shares of Adaptimmune Therapeutics PLC (ADAP) have crossed above the average analyst ...
ADAP Crosses Above Average Analyst Target Thursday, September 17, 8:13 AM ET, by Market News Video Staff In recent trading, shares of Adaptimmune Therapeutics PLC (ADAP) have crossed above the average analyst ...
First Week of ADAP November 20th Options Trading Monday, September 21, 11:12 AM ET, by Market News Video Staff Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options begin trading this week, for the ...
Notable Two Hundred Day Moving Average Cross - ADAP
By Market News Video Staff, Friday, October 16, 4:46 PM ET
In trading on Friday, shares of Adaptimmune Therapeutics PLC (NASDAQ:ADAP) crossed below their 200 day moving average of $6.26, changing hands as low as $6.25 per share. Adaptimmune Therapeutics PLC shares are currently trading off about 20.1% on the day. The chart below shows the one year performance of ADAP shares, versus its 200 day moving average:
Looking at the chart above, ADAP's low point in its 52 week range is $0.709 per share, with $13.40 as the 52 week high point — that compares with a last trade of $6.31.
This Article's Word Cloud:ADAPAdaptimmuneAverageBelowChannelCrossingDividendFridayLookingMovingNewsletterOfferPremiumReceiveSpecialStartStocksTheirTherapeuticsaboutaboveafternoonaveragebelowbestchangingchartcomparescrossedcurrentlydirectlydividendeachhandshighideasinboxlastmdashmovingperformancepointrangeraquosharesharesshowstradingweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Play Video:
Learn About The 200 DMA
Start slideshow: